Allegion (NYSE:ALLE) Stock Rating Lowered by StockNews.com

Allegion (NYSE:ALLEGet Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

ALLE has been the topic of several other research reports. Wells Fargo & Company cut their price objective on Allegion from $152.00 to $140.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 7th. Barclays cut their price target on Allegion from $137.00 to $134.00 and set an “underweight” rating on the stock in a report on Wednesday, January 8th. Mizuho raised their target price on shares of Allegion from $135.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Robert W. Baird raised their price objective on shares of Allegion from $145.00 to $152.00 and gave the company a “neutral” rating in a report on Friday, October 25th. Finally, Morgan Stanley started coverage on Allegion in a report on Monday, January 6th. They set an “equal weight” rating and a $137.00 price target for the company. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $140.83.

Read Our Latest Analysis on ALLE

Allegion Trading Up 1.0 %

Shares of Allegion stock opened at $131.10 on Tuesday. Allegion has a fifty-two week low of $113.27 and a fifty-two week high of $156.10. The company has a debt-to-equity ratio of 1.26, a quick ratio of 1.29 and a current ratio of 1.71. The firm has a market capitalization of $11.40 billion, a price-to-earnings ratio of 20.14, a PEG ratio of 3.35 and a beta of 1.11. The stock has a 50 day moving average of $136.30 and a 200 day moving average of $136.17.

Allegion (NYSE:ALLEGet Free Report) last announced its earnings results on Thursday, October 24th. The scientific and technical instruments company reported $2.16 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.18. Allegion had a net margin of 15.36% and a return on equity of 45.64%. The company had revenue of $967.10 million during the quarter, compared to analyst estimates of $970.70 million. During the same quarter last year, the firm posted $1.94 earnings per share. Allegion’s revenue was up 5.4% compared to the same quarter last year. As a group, research analysts predict that Allegion will post 7.41 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO John H. Stone purchased 7,500 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was acquired at an average price of $140.70 per share, for a total transaction of $1,055,250.00. Following the completion of the purchase, the chief executive officer now directly owns 120,481 shares of the company’s stock, valued at $16,951,676.70. This trade represents a 6.64 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Robert C. Martens sold 8,035 shares of the firm’s stock in a transaction on Friday, October 25th. The stock was sold at an average price of $144.92, for a total transaction of $1,164,432.20. Following the completion of the sale, the senior vice president now owns 7,104 shares of the company’s stock, valued at $1,029,511.68. This trade represents a 53.07 % decrease in their position. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Allegion

A number of institutional investors and hedge funds have recently made changes to their positions in ALLE. McClarren Financial Advisors Inc. lifted its position in shares of Allegion by 61.0% during the 3rd quarter. McClarren Financial Advisors Inc. now owns 190 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 72 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Allegion in the third quarter valued at approximately $28,000. Concord Wealth Partners purchased a new stake in Allegion in the 3rd quarter valued at approximately $29,000. Cromwell Holdings LLC increased its position in Allegion by 65.2% during the third quarter. Cromwell Holdings LLC now owns 233 shares of the scientific and technical instruments company’s stock worth $34,000 after buying an additional 92 shares in the last quarter. Finally, Kimelman & Baird LLC acquired a new stake in shares of Allegion during the second quarter valued at $39,000. 92.21% of the stock is owned by institutional investors and hedge funds.

Allegion Company Profile

(Get Free Report)

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.

Featured Articles

Analyst Recommendations for Allegion (NYSE:ALLE)

Receive News & Ratings for Allegion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allegion and related companies with MarketBeat.com's FREE daily email newsletter.